Omran S A, Hussein N A, Mohamed A A, el-Kaliouby A H, Hussein A T
Department of Clinical Haematology, Theodor Bilharz Research Institute, Giza, Egypt.
J Clin Pathol. 1990 Jun;43(6):476-8. doi: 10.1136/jcp.43.6.476.
Fifty seven patients with schistosomiasis of the liver and spleen in both the compensated and decompensated states and 15 non-bilharzial subjects were studied. Fibrinogen, plasminogen, fibrinogen/fibrin degradation products, alpha 2-macroglobulin, antithrombin III and Cl-activator concentrations were evaluated in an attempt to assess abnormalities at various stages of the disease. The results showed a progressive decrease in fibrinogen and plasminogen concentrations; fibrin degradation products showed a progressive increase as the disease progressed. Together with a falling platelet count, these data indicate the possible occurrence of disseminated intravascular coagulation with enhanced fibrinolysis which was most pronounced in those who vomited blood. Antithrombin III concentration showed a progressive decrease in parallel with the progress of the disease, possibly due to decreased synthesis or increased consumption, or both. Cl-activator concentration showed no significant change from that in normal controls at any stage of the disease. These findings provide further evidence that disseminated intravascular coagulation and enhanced fibrinolysis in the late stages of schistosomiasis may contribute to the haemorrhagic diathesis seen in the liver and spleen.
对57例处于代偿期和失代偿期的肝脾血吸虫病患者以及15例非血吸虫病患者进行了研究。对纤维蛋白原、纤溶酶原、纤维蛋白原/纤维蛋白降解产物、α2-巨球蛋白、抗凝血酶III和Cl-激活剂浓度进行了评估,以试图评估疾病各个阶段的异常情况。结果显示纤维蛋白原和纤溶酶原浓度逐渐降低;随着疾病进展,纤维蛋白降解产物逐渐增加。连同血小板计数下降,这些数据表明可能发生了伴有纤维蛋白溶解增强的弥散性血管内凝血,这在呕血患者中最为明显。抗凝血酶III浓度随着疾病进展逐渐降低,可能是由于合成减少或消耗增加,或两者兼而有之。在疾病的任何阶段,Cl-激活剂浓度与正常对照组相比均无显著变化。这些发现进一步证明,血吸虫病晚期的弥散性血管内凝血和纤维蛋白溶解增强可能导致肝脾出现出血素质。